Financials

  • Market Capitalization 327.7 M
  • Employee 29
  • Founded 1999
  • CEO N/A
  • Website www.faeththerapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG00V3M3TP5
  • Industry N/A
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3176
CAII
Collective Acquisition Corp. II - Class A Ordinary Shares
10.02 USD0.00%+0.10%+0.10%+1.01%339.91 M USD
3199
RREV
RRE Ventures Acquisition Corp. - Class A Ordinary Shares
9.89 USD0.00%-0.10%-0.30%-0.10%329.67 M USD
3227
IACQ
Irenic Acquisition Corp. - Class A Ordinary Shares
9.93 USD+0.10%0.00%+0.10%-0.20%320.46 M USD
3229
CAES
Cantor Equity Partners VII, Inc. - Class A Ordinary Shares
10.05 USD-0.10%+0.20%+0.30%-0.79%320.09 M USD

Frequently asked questions about Faeth Therapeutics, Inc. Common Stock

What is the Faeth Therapeutics, Inc. Common Stock stock price today?

The current price of Faeth Therapeutics, Inc. Common Stock (FTH) is 12.68. Over the past 24 hours, the stock has changed by -42.49%. Follow the FTH chart for real-time price dynamics.

What is the stock ticker of Faeth Therapeutics, Inc. Common Stock?

Faeth Therapeutics, Inc. Common Stock trades under the ticker FTH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Faeth Therapeutics, Inc. Common Stock stock going up?

FTH has changed by -32.73% over the last week, -48.93% over the last month, and -6.00% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Faeth Therapeutics, Inc. Common Stock?

Faeth Therapeutics, Inc. Common Stock currently has a market capitalization of 327.7 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Faeth Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Faeth Therapeutics, Inc. Common Stock reported earnings of -0.79 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Faeth Therapeutics, Inc. Common Stock net income for the last quarter?

Faeth Therapeutics, Inc. Common Stock reported net income of -20.4 M for the last quarter. The previous quarter showed -16.01 M, which means net income changed by -27.43%.

How many employees does Faeth Therapeutics, Inc. Common Stock have?

As of the latest available data, Faeth Therapeutics, Inc. Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Faeth Therapeutics, Inc. Common Stock stock?

You can buy Faeth Therapeutics, Inc. Common Stock (FTH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Faeth Therapeutics, Inc. Common Stock stock?

Investing in Faeth Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the FTH chart and related analysis on metatrader.com as part of your research.